SECRETIN - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for secretin and what is the scope of freedom to operate?
Secretin
is the generic ingredient in three branded drugs marketed by Ferring and Chirhoclin, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.There are six drug master file entries for secretin.
Summary for SECRETIN
| US Patents: | 0 |
| Tradenames: | 3 |
| Applicants: | 2 |
| NDAs: | 3 |
| Drug Master File Entries: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 12 |
| Clinical Trials: | 37 |
| Patent Applications: | 60 |
| DailyMed Link: | SECRETIN at DailyMed |
Recent Clinical Trials for SECRETIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Hepatology & Tropical Medicine Research Institute | Phase 2/Phase 3 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 4 |
| Children's Hospital Medical Center, Cincinnati | Phase 4 |
Medical Subject Heading (MeSH) Categories for SECRETIN
Anatomical Therapeutic Chemical (ATC) Classes for SECRETIN
US Patents and Regulatory Information for SECRETIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferring | SECRETIN-FERRING | secretin | INJECTABLE;INJECTION | 018290-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chirhoclin | SECREFLO | secretin synthetic porcine | FOR SOLUTION;INTRAVENOUS | 021136-001 | Apr 4, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chirhoclin | CHIRHOSTIM | secretin synthetic human | FOR SOLUTION;INTRAVENOUS | 021256-002 | Jun 21, 2007 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chirhoclin | CHIRHOSTIM | secretin synthetic human | FOR SOLUTION;INTRAVENOUS | 021256-001 | Apr 9, 2004 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
